RYE, N.Y.–(BUSINESS WIRE)–The Board of Trustees of The Gabelli Healthcare & WellnessRx
Trust (NYSE:GRX) (the “Fund”) reaffirmed its quarterly distribution
policy and declared a $0.14 per share cash distribution payable on June
21, 2019 to common shareholders of record on June 14, 2019.
The Fund intends to pay a quarterly distribution of an amount determined
each quarter by the Board of Trustees. The Board of Trustees may change
the amount of the quarterly distribution at any time. In addition to the
quarterly distributions, and in accordance with the minimum distribution
requirements of the Internal Revenue Code for regulated investment
companies, the Fund may pay an adjusting distribution in December which
includes any additional income and net realized capital gains in excess
of the quarterly distributions for that year.
Each quarter, the Board of Trustees reviews the amount of any potential
distribution and the income, realized capital gain, or capital
available. The Board of Trustees will continue to monitor the Fund’s
distribution level, taking into consideration the Fund’s net asset value
and the financial market environment. The Fund’s distribution policy is
subject to modification or termination by the Board of Trustees at any
time, and there can be no guarantee that the policy will continue. The
distribution rate should not be considered the dividend yield or total
return on an investment in the Fund.
All or part of the distribution may be treated as long-term capital gain
or qualified dividend income (or a combination of both) for individuals,
each subject up to the maximum federal income tax rate, which is
currently 20% in taxable accounts for individuals (or less depending on
an individual’s tax bracket). In addition, certain U.S. shareholders who
are individuals, estates or trusts and whose income exceeds certain
thresholds will be required to pay a 3.8% Medicare surcharge on their
“net investment income”, which includes dividends received from the Fund
and capital gains from the sale or other disposition of shares of the
Fund.
If the Fund does not generate sufficient earnings (dividends and
interest income, less expenses, and realized net capital gain) equal to
or in excess of the aggregate distributions paid by the Fund in a given
year, then the amount distributed in excess of the Fund’s earnings would
be deemed a return of capital. Because this would be considered a return
of a portion of a shareholder’s original investment, it is generally not
taxable and would be treated as a reduction in the shareholder’s cost
basis.
Long-term capital gains, qualified dividend income, ordinary income, and
return of capital, if any, will be allocated on a pro-rata basis to all
distributions to common shareholders for the year. Based on the
accounting records of the Fund currently available, each of the
distributions paid to common shareholders in 2019 would include
approximately 3% from net investment income and 97% from net capital
gains on a book basis. This does not represent information for tax
reporting purposes. The estimated components of each distribution are
updated and provided to shareholders of record in a notice accompanying
the distribution and are available on our website (www.gabelli.com).
The final determination of the sources of all distributions in 2019 will
be made after year end and can vary from the quarterly estimates.
Shareholders should not draw any conclusions about the Fund’s investment
performance from the amount of the current distribution. All individual
shareholders with taxable accounts will receive written notification
regarding the components and tax treatment for all 2019 distributions in
early 2020 via Form 1099-DIV.
Investors should carefully consider the investment objectives, risks,
charges, and expenses of the Fund before investing. More
information regarding the Fund’s distribution policy and other
information about the Fund is available by calling 800-GABELLI
(800-422-3554) or visiting www.gabelli.com.
The Gabelli Healthcare & WellnessRx Trust is a
diversified, closed-end management investment company with $290 million
in total net assets whose primary investment objective is long-term
growth of capital. The Fund is managed by Gabelli Funds, LLC, a
subsidiary of GAMCO Investors, Inc. (NYSE:GBL).
Contacts
For information:
Bethany Uhlein
(914) 921-5070
